Katharina Kiss is a global entrepreneur and Consultant Clinical and Interventional Cardiologist with more than 25 years of experience in structural heart innovation.
Katharina Kiss is a global entrepreneur and Consultant Clinical and Interventional Cardiologist
with more than 25 years of experience in structural heart innovation. As CEO of P+F Products
and Features GmbH (since 2001), P&F US Inc., Cardiovascular in Brazil, KK International, and
P&F Cardio Ltd., she leads the development, in-house manufacturing, regulatory strategy, and
worldwide commercialization of minimally invasive cardiovascular devices for patients at high
surgical risk.
Her portfolio comprises the full range of transcatheter heart valves, aortic, mitral, tricuspid, and
pulmonary, including the flagship Tricvalve system, the Endobental transcatheter system for
combined aortic valve and ascending aortic replacement, and patient-specific stent-graft
systems for thoracic, abdominal, and peripheral aortic disease, all delivered under a fully
vertically integrated model. She holds the Austrian Meisterprüfung for medical device
manufacture and is an Honorary Professor recognized for Clinical Excellence.